Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,200 | -19,288 | -53,552 | -49,146 | -29,140 |
| Depreciation Amortization | 1,089 | 477 | 1,079 | 796 | 510 |
| Accounts receivable | 4,871 | 5,327 | -13,441 | -2,202 | -3,425 |
| Other Working Capital | 13,817 | 5,194 | -20,171 | -5,417 | -8,916 |
| Other Operating Activity | 718 | -2,460 | 21,806 | 8,558 | 7,858 |
| Operating Cash Flow | $-21,705 | $-10,750 | $-64,279 | $-47,411 | $-33,113 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -48,947 | -48,947 | N/A | N/A | N/A |
| PPE Investments | -614 | -534 | -1,413 | -873 | -706 |
| Investing Cash Flow | $-49,561 | $-49,481 | $-1,413 | $-873 | $-706 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 29,661 | N/A | N/A |
| Common Stock Issued | 67 | 57 | 83,157 | 83,073 | 83,382 |
| Other Financing Activity | -374 | -309 | 0 | 0 | -347 |
| Financing Cash Flow | $-307 | $-252 | $112,818 | $83,073 | $83,035 |
| Beginning Cash Position | 99,501 | 99,501 | 52,375 | 52,826 | 52,826 |
| End Cash Position | 27,928 | 39,018 | 99,501 | 87,615 | 102,042 |
| Net Cash Flow | $-71,573 | $-60,483 | $47,126 | $34,789 | $49,216 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,705 | -10,750 | -64,279 | -47,411 | -33,113 |
| Capital Expenditure | -614 | -534 | -1,413 | -873 | -706 |
| Free Cash Flow | -22,319 | -11,284 | -65,692 | -48,284 | -33,818 |